The Latest: Italy: Additional 7M Pfizer doses by end of June

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

A medical staff member administers a dose of Moderna's COVID-19 vaccine in Rome, Wednesday, April 14, 2021. (Cecilia Fabiano/LaPresse via AP)

MILAN — Italy is set to receive an additional 7 million doses of the Pfizer vaccine by the end of June.

“Finally, a bit of good news,” the commissioner for Italy’s COVID emergency, Franceso Paolo Figliuolo, says Wednesday from the tiny northern region of Aosta.

He says the additions were the result of an increase in arrivals to Europe of 50 million Pfizer doses. It is the third boost in doses of the Pfizer vaccine ordered by Italy, which already was set to receive some 25 million doses by the end of June.

Get Johnson & Johnson alerts:

Italy has put on hold the Johnson & Johnson vaccine, following the warning from the U.S. Food and Drug Administration. First J&J deliveries arrived on Tuesday and were set to reach 7.3 million by the end of the quarter.

___

THE VIRUS OUTBREAK:

— EU plans Pfizer vaccine contract extension to 2023

— Biden says pause on J&J shots shows govt putting safety 1st

— EXPLAINER: What’s known about COVID vaccines and rare clots

— The postponed Tokyo Olympics open in 100 days, but nothing is certain these days

— Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine

___

HERE’S WHAT ELSE IS HAPPENING:

LONDON — European countries are diverging on whether to push ahead with giving residents Johnson & Johnson’s COVID-19 vaccine after reports of rare blood clots in a handful of recipients in the United States. Some leaders opted for caution Wednesday after U.S. officials paused the vaccine’s use while they study the clots in a handful of people.

Italy, the Netherlands, Croatia and Denmark put their Johnson & Johnson lots in storage while waiting for guidance from European health officials. But Poland and France said they would administer the doses they received.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

Experts agree COVID-19 poses a much larger risk of hospitalization and death than the potential threat of atypical clots.

The AstraZeneca vaccine is in wide use around the globe, though not yet in the U.S. Several countries have imposed age restrictions on its use because of blood clot concerns. Denmark, which put the vaccine on hold last month, decided Wednesday not to resume using the shots it had on hand. It will offer a second dose of a different vaccine if citizens had received a first dose of AstraZeneca.

___

SAN JUAN, Puerto Rico — The government of Trinidad and Tobago says it is closing all beaches in the twin-island nation for three weeks to stem a rise in coronavirus cases.

Officials also say they’re banning indoor dining at restaurants, bars and casinos. Only groups of five, instead of 10, will be allowed to gather in public. The measures take effect at midnight Thursday.

Trinidad and Tobago had previously canceled one of the biggest carnival celebrations in the Caribbean for this year.

The nation of 1.2 million people has reported more than 8,500 cases and more than 140 confirmed deaths. Among those who have tested positive for coronavirus is Prime Minister Keith Rowley. More than 10,000 people have been vaccinated so far.

___

LONDON — The European Medicines Agency is assessing the rare blood clots reported in the U.S. after receiving the Johnson & Johnson COVID-19 vaccine, and a recommendation for European countries is expected soon.

“EMA is expediting this evaluation and currently expects to issue a recommendation next week,” the EMA says. The agency authorized the J&J shot for use across the 27-bloc EU last month, although no countries had started widespread vaccination campaigns with it.

“EMA remains of the view that the benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects.”

The EU drug regulator says it was investigating the six cases reported among nearly 7 million people vaccinated with the single-dose J&J shot. The EMA says it was in contact with officials at the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention about their ongoing probe.

The rare blood clots, in combination with a low level of blood platelets, caused American officials to pause the vaccine while they investigate.

___

MADISON, Wis. — The Wisconsin Supreme Court says Gov. Tony Evers’ administration doesn’t have the authority to issue capacity limits on bars, restaurants and other businesses without approval of the Legislature.

The ruling comes two weeks after the conservative-controlled court struck down the state’s mask mandate.

The Supreme Court also ruled last year in a similar case, saying the Democratic governor needed legislative approval for an emergency declaration that shut down businesses early in the coronavirus pandemic.

There hasn’t been a statewide capacity limit restriction in place since October.

The Supreme Court ruled 4-3 on Wednesday the order issued by Evers’ Department of Health Services meets the definition of a rule, which by law must go through the Republican-controlled Legislature. The court’s four conservative justices ruled against Evers, while three liberals dissented.

___

HELSINKI — Health officials in Finland announced the country will keep using the AstraZeneca vaccine and only administer it to people age 65 and over as it has done since late March.

Finland temporarily suspended the AstraZeneca vaccine for more than a week on March 19 after brain blood clots were diagnosed in two individuals who had received the jab. It continued administering it later the same month to people 65 and over.

“They have not been found to have an increased risk of developing very rare blood clotting problems after vaccination,” said Chief Physician Hanna Nohyek at the Finnish National Institute for Health and Welfare.

Three blood clot cases have been reported in Finland, a nation of 5.5 million, with the nearly 250,000 people receiving the shot by AstraZeneca.

All three cases were diagnosed in patients under 65, health officials say.

___

BRUSSELS — The head of the European Union’s executive arm has announced plans for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023.

European Commission President Ursula von der Leyen said Wednesday that the EU will start negotiating to buy 1.8 billion doses of the Pfizer vaccine through 2023. Pfizer has been a mainstay of the EU’s vaccination drive so far.

Von der Leyen expressed full confidence in the technology used for the Pfizer vaccine, which is different from the technology behind the AstraZeneca vaccine.

Pfizer plans to provide the EU with an extra 50 million doses in the second quarter of this year, on top of 200 million doses already earmarked for the bloc. The deliveries will be especially welcomed by the EU’s 27 member nations considering supply delays and concerns about rare blood clots potentially linked to the AstraZeneca vaccine.

___

MOSCOW — Russian President Vladimir Putin says he has gotten his second COVID-19 vaccine shot, three weeks after getting the first dose.

The Russian leader announced getting the jab, which was kept out of the public eye, at a session of the Russian Geographical Society on Wednesday, in which he took part via video link.

“Right now, before entering this hall, I have also gotten the second jab. I hope everything will be fine. I don’t even hope as much as I’m sure of it,” Putin said.

Putin got his first coronavirus shot on March 23, also out of sight of the cameras, and the Kremlin wouldn’t reveal which of the three vaccines currently approved for use in Russia the president has taken.

The Russian leader’s vaccination comes several months after widespread immunization against COVID-19 started in Russia — a delay that puzzled many, with some critics arguing that it was contributing to the already existing public hesitancy about the vaccine.

Russian authorities have given regulatory approval to three domestically developed shots — Sputnik V, EpiVacCorona and CoviVac. All three received authorization before completing advanced trials experts say are necessary to ensure their safety and effectiveness in line with established scientific protocol.

___

BANGKOK — Thailand reported more than 1,300 new COVID-19 infections on Wednesday, setting another daily record.

It adds pressure on the government to speed up a nearly nonexistent vaccination drive and do more to control a surge that comes amid mass travel as the country celebrates its traditional New Year festival.

The 1,335 new infections brings the number of new cases to nearly 7,000 since April 1, when a cluster was linked to nightclubs and bars in central Bangkok. Most of the new cases reported Wednesday were yet again in Bangkok. There were also large increases in the northern province of Chiang Mai and the southern seaside province of Prachuap Khiri Khan.

Many of the new infections are a more contagious variant of the virus first found in Britain. Coupled with widespread travel for the Songkran festival, or Thai New Year, that is fueling the surge, said Dr. Opas Karnkavinpong, director-general of the Disease Control Department. The festival officially began Tuesday and lasts for three days, but many people travel for a week.

___

BUCHAREST, Romania — Romania’s prime minister fired the country’s health minister Wednesday, after a series of incidents related to the COVID-19 pandemic created tensions within the governing coalition.

The move came a day after Health Minister Vlad Voiculescu reportedly made changes to the criteria the government uses to determine which virus-control restrictions to impose on local areas without informing Prime Minister Florin Citu.

Citu said the leader of USR-PLUS political alliance, Dan Barna, will serve as interim health minister.

Voiculescu was appointed in December and briefly served as Romania’s health minister in 2016. He had promised to reform the nation’s strapped health care system.

“Voiculescu meant well and insured the ministry at a critical moment in time, but it’s hard to reform an ailing system in a few months, not to mention with COVID-19 at full speed,” Radu Magdin, a Bucharest-based analyst, told The Associated Press.

___

WARSAW, Poland – Poland plans to go ahead with immunizations using the Johnson & Johnson vaccine after receiving its first batch of 120,000 doses on Wednesday.

Health Minister Adam Niedzielski said Poland is following the latest recommendations from the European Medicines Agency, which said it is “currently not clear” whether the J&J shot caused rare blood clots reported in some recipients. The EMA approved the vaccine for use in the European Union last month.

“In line with these recommendations, we will want to use it in inoculations,” Niedzielski said.

The Food and Drug Administration on Tuesday temporarily paused Johnson & Johnson shots in the United States to investigate possible links to blood clots in six women six to 13 days after vaccination.

Poland is trying to speed up its vaccination drive amid high numbers of daily coronavirus cases and COVID-19-related deaths. Niedzielski said some 75% of COVID-19 hospital beds are taken.

The country of some 38 million people has administered almost 8 million doses of the Pfizer, Moderna and AstraZeneca vaccines.

___

MUMBAI — India’s worst-hit and richest state India’s worst-hit and richest state Maharashtra will impose stricter restrictions for 15 days on Wednesday in an effort to stem the surge of coronavirus infections that is threatening to overcome hospitals.

Top Maharashtra state officials stressed that the closure of most industries, businesses, public places and limits on the movement of people didn’t constitute a lockdown.

Last year, a sudden, harsh, nationwide lockdown left millions of people in India jobless overnight. Stranded in cities with no income or food, thousands of migrant workers walked on highways to get home. Since then, state leaders have repeatedly stressed that another lockdown wasn’t in the cards.

India on Wednesday reported over 180,000 new coronavirus cases in the past 24 hours, about a third in Maharashtra state, and a total of 13.9 million cases in the pandemic.

Maharashtra Chief Minister Uddhav Thackeray said that most public places, shops and establishments will be shut for 15 days starting 8 p.m. Wednesday, except for essential services like grocery stores and bank..

___

MADRID — Spain’s prime minister says his government is maintaining its goal of immunizing 70% of the nation’s adult population, some 33 million people, by the end of the summer despite the delay in the European rollout of the Johnson & Johnson vaccine.

Spain was expecting to receive 300,000 doses of the Janssen vaccine on Wednesday, the first delivery of the jab produced by Johnson & Johnson. The country wants to prioritize people aged between 70 and 79 to receive the single-dose vaccine.

But those plans had to be put on hold after the pharmaceutical company delayed delivery of the vaccine to European countries following the decision by the U.S. Food and Drug Administration to pause the shots in the United States to investigate possible links to very rare blood clots.

The hold up comes after various delays in shipments of other vaccines and a similar blood clot scare with the AstraZeneca vaccine that led Spain to limit it to people over 60 years old.

Prime Minister Pedro Sánchez, however, told Spain’s Parliament on Wednesday that “the pace of vaccination is going to accelerate in the month of April and (…) we will meet out goal.”

___

BERLIN — German health authorities are recommending that people younger than 60 who have already received one shot of the AstraZeneca vaccine use a different vaccine for their second dose over concerns of blood clots.

The Health Ministry said Wednesday that it was recommending that people in that category receive as their second shot either the Pfizer-BioNTech or Moderna vaccine, both of which were developed using a different process.

It says, however, that in individual cases younger people wanting a second AstraZeneca shot can get one so long as they have a careful medical risk assessment. That also applies to high-risk people under the age of 60 still awaiting their primary vaccination.

The reports of rare blood clots in some people who’ve received the vaccine prompted Germany and several other countries in the 27-nation European Union to limit the AstraZeneca shots to older age groups, who are more at risk from serious illness when infected with COVID-19.

___

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Should you invest $1,000 in Johnson & Johnson right now?

Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report